Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psoriatic arthritis update.

Philip Mease1

  • 1Seattle Rheumatology Associates, Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington, USA.

Bulletin of the NYU Hospital for Joint Diseases
|November 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature review.

RMD open·2026
Same author

Artificial intelligence versus experts: Navigating challenging cases in psoriatic disease.

The Journal of investigative dermatology·2026
Same author

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.

Annals of the rheumatic diseases·2026
Same author

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study.

Annals of the rheumatic diseases·2026
Same author

A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole Patient.

Rheumatology and therapy·2026
Same journal

Mosaicplasty for the treatment of the osteochondral lesion in the femoral head.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Hibernoma--a case series with multimodality imaging and pathologic correlation.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Progressive migration of broken Kirschner wire into the proximal tibia following tension-band wiring technique of a patellar fracture--case report.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Multidrug-resistant Acinetobacter baumannii infection following para-articular steroid injection in the knee--a case report.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Extensor indicis proprius and extensor digitorum communis rupture after volar locked plating of the distal radius--a case report.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Bilateral four-part anterior fracture dislocation of the shoulder--a case report and review of literature.

Bulletin of the NYU hospital for joint diseases·2012
See all related articles

Psoriatic arthritis, an inflammatory condition affecting psoriasis patients, is increasingly understood. Biologic agents, particularly anti-TNF therapies, offer significant benefits for skin and joint symptoms, improving quality of life.

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Psoriatic arthritis (PsA) affects up to 30% of psoriasis patients.
  • PsA is clinically, genetically, and immunologically distinct from rheumatoid arthritis.
  • Updated classification criteria and understanding of pathophysiologic pathways are emerging.

Purpose of the Study:

  • To review current understanding and therapeutic approaches for psoriatic arthritis.
  • To highlight advancements in outcome measures and biologic therapies.

Main Methods:

  • Review of clinical, genetic, and immunohistological data.
  • Evaluation of traditional and biologic treatment strategies.
  • Assessment of outcome measures for disease domains including skin, joints, and quality of life.

Related Experiment Videos

Main Results:

  • Biologic agents, especially anti-TNF therapies, demonstrate significant benefits across multiple domains (skin, joints, function, quality of life).
  • Biologics can inhibit structural damage progression.
  • Traditional therapies have limitations in efficacy and may cause toxicity.

Conclusions:

  • Biologic therapies represent a major advancement in managing psoriatic arthritis.
  • Ongoing research focuses on refining outcome measures and understanding treatment targets.
  • Cost-effectiveness of biologic agents is a consideration, with analysis showing reasonable benefit-risk.